Kuwait Pharmaceutical Cro Market Size & Outlook, 2025-2030

The pharmaceutical cro market in Kuwait is expected to reach a projected revenue of US$ 575.7 million by 2030. A compound annual growth rate of 8.3% is expected of Kuwait pharmaceutical cro market from 2025 to 2030.
Revenue, 2024 (US$M)
$358.0
Forecast, 2030 (US$M)
$575.7
CAGR, 2025 - 2030
8.3%
Report Coverage
Kuwait

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait pharmaceutical cro market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait pharmaceutical cro market highlights

  • The Kuwait pharmaceutical cro market generated a revenue of USD 358.0 million in 2024 and is expected to reach USD 575.7 million by 2030.
  • The Kuwait market is expected to grow at a CAGR of 8.2% from 2025 to 2030.
  • In terms of segment, clinical was the largest revenue generating type in 2024.
  • Pre-Clinical is the most lucrative type segment registering the fastest growth during the forecast period.


Pharmaceutical cro market data book summary

Market revenue in 2024USD 358.0 million
Market revenue in 2030USD 575.7 million
Growth rate8.2% (CAGR from 2024 to 2030)
Largest segmentClinical
Fastest growing segmentPre-Clinical
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDrug Discovery, Pre-Clinical, Clinical


Other key industry trends

  • In terms of revenue, Kuwait accounted for 0.9% of the global pharmaceutical cro market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa pharmaceutical cro market is projected to lead the regional market in terms of revenue in 2030.
  • Kuwait is the fastest growing regional market in Middle East & Africa and is projected to reach USD 575.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pharmaceutical CRO Market Companies

Name Profile # Employees HQ Website
CTI Clinical Trial and Consulting Services View profile 501-1000 Covington, Kentucky, United States, North America http://ctifacts.com
PAREXEL View profile 10001+ Waltham, Massachusetts, United States, North America http://www.parexel.com
IQVIA Holdings Inc View profile 87000 2400 Ellis Road, Durham, NC, United States, 27703 https://www.iqvia.com
Medpace Holdings Inc View profile 5800 5375 Medpace Way, Cincinnati, OH, United States, 45227 https://www.medpace.com
Wuxi AppTec Co Ltd View profile 41116 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 https://www.wuxiapptec.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Kuwait pharmaceutical cro market size, by type, 2018-2030 (US$M)

Kuwait Pharmaceutical CRO Market Outlook Share, 2024 & 2030 (US$M)

Kuwait pharmaceutical cro market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online